Retrospective Analysis of the French National Cohort of Patients With GAD Antibodies and Cerebellar Ataxia

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

June 30, 2024

Conditions

GAD-receptor Antibodies-associated Encephalitis

Interventions

OTHER

GAD patients

Describe the clinical and demographic characteristics of patients with anti-GAD65 antibody associated cerebellar ataxia.

Trial Locations (1)

RECRUITING

Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER